|
HS Code |
842922 |
| Name | Salvianolic Acid B |
| Cas Number | 115939-25-8 |
| Molecular Formula | C36H30O16 |
| Molecular Weight | 718.62 g/mol |
| Appearance | Brownish yellow powder |
| Solubility | Soluble in water, methanol, and ethanol |
| Purity | ≥98% (HPLC) |
| Storage Temperature | 2-8°C (Refrigerated) |
| Source | Salvia miltiorrhiza (Danshen) |
| Chemical Class | Polyphenolic compound |
| Synonyms | Sal B; Salvianolate B |
| Stability | Stable under recommended storage conditions |
| Inchi Key | JTXPZBIBXKYZPD-QGXQPMFNSA-N |
As an accredited Salvianolic Acid B factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Salvianolic Acid B, 100 mg, supplied in a sealed amber glass vial with tamper-evident cap and detailed labeling for research use. |
| Shipping | Salvianolic Acid B is shipped in a tightly sealed, light-resistant container to maintain stability and prevent degradation. It is usually transported as a solid or powder and packed securely with appropriate labeling. Standard precautions for chemical handling are followed, ensuring compliance with safety and regulatory guidelines during shipping. |
| Storage | Salvianolic Acid B should be stored in a tightly sealed container, protected from light and moisture. Keep it at -20°C or lower to ensure stability and prevent degradation. Avoid repeated freeze-thaw cycles. Handle under inert atmosphere if possible, and store away from strong oxidizing agents. Ensure proper labeling and use personal protective equipment when handling the compound. |
Competitive Salvianolic Acid B prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the last two decades, Salvianolic Acid B has shaped an intriguing path across extraction technology, pharmacological research, and industrial applications. As a direct manufacturer with years of hands-on experience, the significance of each step—right from Dianthus root harvesting, precision in extraction, to analytical characterization—holds weight both for quality and reliability. Our plant sources are cultivated under carefully managed soil and climate conditions, because the compound concentration swings with small changes in growing environments. Root washing and sorting follow old methods, but the real transformative leap happened with column chromatography and modern purification tools. These tools, handled by skilled workers, make it possible to offer Salvianolic Acid B reaching up to 98% HPLC purity as a crystalline powder. Subtle differences in drying times or filtration steps can leave residual moisture or by-products. Here, technician experience leaves a bigger mark than any automated checklist.
Many customers ask why researchers and supplement developers focus on Salvianolic Acid B over the dozens of similar molecules in the Salvia miltiorrhiza root. While rosmarinic acid or salvianolic acid A have their own properties, Salvianolic Acid B stands out for its water solubility and unique polyphenolic structure. This makes it easily incorporated into aqueous buffers for pharmaceutical and biochemical studies, without the need for large amounts of solubilizers or co-solvents that risk interfering with bioassays. Laboratory teams tell us that this single feature eases method development in antioxidant or cell protection studies. Many competing products from small extraction houses or unregulated sources come mixed with other related salvianolic acids, which can skew activity results or analytical data. Our method uses targeted fractionation paired with rigorous TLC and HPLC fingerprinting, so every lot maintains compound consistency and traceability.
Researchers who choose Salvianolic Acid B often target oxidative stress pathways, vascular protection, or experimental models of inflammation. The polyphenolic backbone scavenges free radicals more efficiently compared to smaller hydroxycinnamic acids. One university collaboration highlighted improved neuronal survival rates using our material alongside other plasma-derived antioxidants. In the context of cardiovascular models, our material’s purity has allowed clear dose-response data with less background noise compared to mixtures that contain high levels of Salvianolic Acid A or uncharacterized fractions. Clinicians and method developers appreciate our batch certificates that provide contaminant testing—especially since some pharmacopoeial standards do not yet address botanical impurities that may arise in lower-tier lots.
Not all end uses require the same grade or form. For in vitro mechanistic studies, powders above 98% HPLC purity help minimize cell stress unrelated to the active component. Pharmaceutical developers have asked for custom micronization to match excipient compatibility. Encapsulation applications sometimes favor a slightly lower purity around 90%—this can save cost while still delivering high active content. Our on-site analytical team employs UV-Vis, HPLC and NMR testing at several process steps, ensuring the product profile aligns with documented benchmarks. Raw powder appears as a faint brown to dark reddish solid; even subtle color shifts indicate minor changes in the polyphenolic mix and moisture level, which are tracked for consistency.
Plant-derived products face more scrutiny now than ever, especially with the growing number of supplement recalls and regulatory investigations. Manufacturers who source uneven or mixed-batch raw material frequently run into issues that only show up after scale-up. By keeping a tight production loop—root sourcing, extraction, and purification all controlled under one roof—the result is a stronger analytical record for each shipment. Our teams submit periodic samples to independent testing agencies for pesticide, mycotoxin, and heavy metal compliance. This approach not only smooths downstream product registrations, it gives researchers and formulators deeper confidence in planning clinical projects or long-term toxicology work. Traceability is not just paperwork—each Salvia miltiorrhiza batch from which we isolate Salvianolic Acid B holds a tracking number that connects chemical identity to its physical origin and date of processing.
Years of experience have shown us how weather patterns or supply disruptions affect root yield and active content. Wet seasons can raise soil pathogens, while extreme sun can stunt root phenolic concentration. The extraction process itself poses bottlenecks; too high of a solvent temperature can break down desired polyphenols, while overly gentle parameters fail to pull out the full spectrum. Hands-on adjustments and precise documentation at each production stage improve batch after batch. During COVID supply disruptions, some producers substituted related plant species or offered extracts with unverified Salvianolic Acid B analogs. From both a safety and research perspective, these substitutions risked undermining months of downstream study. Insisting on continuous sourcing transparency and validating each chemical fingerprint before dispatch is the only realistic way to protect the integrity of every research and health application.
Many new clients ask about the distinctions between Salvianolic Acid B and other derivatives like salvianolic acid A or danshensu. All three share some polyphenolic core, but Salvianolic Acid B’s larger, more complex structure brings major differences in reactivity and solubility. Salvianolic Acid A remains less water-soluble, demanding more organic solvents during formulation, with potential for precipitation issues. Danshensu, while potent in its own right, does not offer the free radical scavenging power documented for Salvianolic Acid B. Large-scale chromatograms show different elution profiles for each, and our chemists often run multiple columns to avoid cross-contamination between these closely related molecules. Some external suppliers blend extracts or sell mixed fractions, which can produce unreliable results in downstream bioassays or early clinical work. By sticking to pure isolation and rigorous cross-batch testing, each shipment upholds reliable structure and performance.
Pharmaceutical developers, supplement manufacturers, and laboratory teams each use Salvianolic Acid B differently. For supplement formulation, the focus often falls on cardiovascular or cognitive health categories, relying on the compound’s literature-supported role in vascular and neuronal protection. In the pharmaceutical setting, Salvianolic Acid B supports both mechanism-of-action studies and formulation work where water solubility and antioxidant capability matter most. Researchers who model ischemia, oxidative brain injury, or systemic inflammation select Salvianolic Acid B for its ability to interact with both radicals and protein targets in aqueous systems. These teams report that its stable, crystalline powder form streamlines study setup, reproducibility and transferability—a step above crude extracts or impure blends.
Plant phenolic compounds often appear robust, but they degrade under prolonged exposure to heat, light, or oxygen. Bulk Salvianolic Acid B ships in sealed, inert-atmosphere containers whenever practical. During storage, desiccators and low temperature environments help maintain the compound’s integrity and appearance. The powder picks up moisture from room air, leading to subtle clumping or brownish discoloration if left unsealed. Our facility stresses minimal transfer steps and rapid packaging after purifying each batch. By controlling carbonyl contamination and residual solvent traces, end-users see not only better shelf life but tighter batch-to-batch consistency. For research or blending purposes, fresh dilutions in cold aqueous buffers yield best results.
Projects spanning supplement launches to clinic-scale research have shown that small compromises in extraction or purification lead to outsized headaches for end users. We’ve witnessed clients with pilot-scale batches sourced elsewhere run into regulatory or QA setbacks over undeclared impurities or inconsistent active content. Our technical team works alongside formulation chemists and quality controllers, troubleshooting compatibility with common capsule excipients and buffer systems. Sometimes even capsule colorants or binders can interact with polyphenols, changing release profiles or appearance. Sharing real HPLC curves and impurity data early during customer trials prevents missteps and sets up smoother regulatory submissions.
The chemical industry faces constant pressure to innovate while upholding higher standards each year. Authentic plant-derived products like Salvianolic Acid B require as much attention to sustainability and customer communication as to chemistry. Our process now includes annual feedback cycles with key clients—both multinational supplement players and small academic labs. Their priorities have steered us toward improved documentation, shorter batch lead times, and flexible batch sizes that serve both field-scale research and scaled manufacturing. On the innovation front, chromatography technique improvements have nudged extraction recoveries up while using less solvent per kilogram, reducing environmental impact and lowering downstream refining costs. Direct experience with regulatory agencies and academic partners keeps us pushing for greater transparency in every COA and technical document.
Salvianolic Acid B’s rise from a research curiosity to a widely used plant compound underscores the need for honesty at every stage—from root cultivation to batch packaging. Every year brings new studies on mechanisms, dosing, and potential benefits, but also fresh scrutiny from regulators and consumers. Our role stays clear: offer a reliable, well-characterized product whose quality supports both current and future work. By staying involved with each customer, we gain insight into evolving needs, whether that means supporting double-blind clinical trial sourcing or troubleshooting new analytical pathways. True progress comes from long-term partnerships, not one-off transactions or unseen ingredient swaps.
Agricultural supply faces climate shifts and unpredictable market forces. The demand for clinical-grade botanical ingredients will only grow tougher. Each new regulation or safety standard ratchets up expectations for source transparency and lab documentation. Competing on price alone rarely supports the type of research and supplement development that leads to trustworthy results and safe consumer products. Our ongoing investment in skilled technicians, advanced equipment, and transparent batch management positions us to keep meeting these higher bars. Experience has taught us what pitfalls to avoid and which partnerships help our customers succeed, whether in a university cell culture lab or a commercial-scale manufacturing plant.
The path from raw root to pure Salvianolic Acid B has never followed a straight line. Every harvest, batch adjustment, and order lends a new lesson. Our team brings together years of chemical know-how, plant cultivation, and straightforward troubleshooting learned on the factory floor and in customer labs. The future will see more rigorous science, closer oversight, and broader use of plant-derived actives like Salvianolic Acid B. Succeeding in this space depends as much on honest conversation with end users as it does on technical process improvements or purity claims. With ongoing feedback and transparent collaboration, we keep moving the bar higher for both quality and trust.